In February 2020, the FDA recalled the popular weight loss drug, Belviq because of an increased risk to cancer. Lawsuits are being filed right now on behalf of individuals who believe their cancer diagnosis may be linked to Belviq.
SimplyConvert’s proprietary Instant Case Evaluation Platform can help your team seek justice for people who took the drug and suffered personal injuries.
We partner with the most qualified lawyers in every mass tort to formulate the criteria for qualifying clients. Once we program our AI-powered chatbot with the litigation-specific criteria, it is ready to chat with website visitors and qualify potentially viable claims for the litigation.
Firms on the SimplyConvert platform can immediately begin case intake for the litigation. (If your team wishes to modify the criteria, we are happy to discuss how we can revise it to work for your practice.) As will all of our Instant Case Evaluators, no litigation-specific training is required.
From the first conversation to a signed contract, SimplyConvert's automation tools put every step of the client intake process on autopilot. If you’re not already using the SimplyConvert platform, get started today and get back to focusing on your clients.